Showing 1 - 10 of 1,088
In any assessment of the R&D capabilities of Indian companies, their patent holdings would have to be examined. Here we identify the number of patents assigned by four foreign governments to Indian pharmaceutical and biotechnological companies up to December 31, 2009. It is known that the United...
Persistent link: https://www.econbiz.de/10014130598
A comparative study is undertaken that explores Chinese and Indian pharmaceutical industries under different patent regimes. It is found that relative to India, which had implemented process patent until 2005, China with a product patent regime since 1993 suffers from both lower drug...
Persistent link: https://www.econbiz.de/10003725601
Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...
Persistent link: https://www.econbiz.de/10011337690
This paper attempts to evaluate the possible gains and losses arising from the gradual opening up of pharmaceutical trade between India and Pakistan. We explain the comparative advantages of both countries at a disaggregated level, followed by a qualitative analysis of various perceptions and...
Persistent link: https://www.econbiz.de/10010460866
This study of the Indian Pharmaceutical Industry (IPI) attempts to identify existing and proposed business models for the choice of strategic options for the success of the Indian pharmaceutical industry in the New Patent Regime. As part of the study, a number of company and industry reports,...
Persistent link: https://www.econbiz.de/10013066289
In the present paper, it is attempted to empirically verify the impact of economic liberalization on the R&D behaviour of Indian pharmaceutical firms controlling for the effects of several firm specific characteristics including firm size. The results from the Tobit analysis for a sample of...
Persistent link: https://www.econbiz.de/10013153453
Persistent link: https://www.econbiz.de/10012957025
Intellectual capital (IC) is becoming a major part of companies' value in today's knowledge-based economy. To manage and control IC requires companies to not only identify, but measure and report internally on IC. Intellectual capital reporting concept has been gaining increasing importance in...
Persistent link: https://www.econbiz.de/10013002298
The business organizations have a propensity to show their performances by achieving greater sales performances in the field. In this, the role of sales force of high importance and the organizations are adopting dynamic marketing and selling strategies and implementing those strategies to their...
Persistent link: https://www.econbiz.de/10013027188
The global pharmaceutical industry is in an era of greater uncertainty because of looming patent expiries of established drugs having a direct impact on their sales and profitability. Further discovering new drugs in-house is a risky, time consuming and expensive proposition. This has forced...
Persistent link: https://www.econbiz.de/10012994958